Carol was looking for treatment options for her stage IV glioblastoma, a type of brain cancer. http://www.cancerresearch.org/june

She found a Cancer Research Institute-funded immunotherapy clinical trial testing a combination of treatments--the anti-PD-L1 checkpoint inhibitor durvalumab and the anti-angiogenic drug bevacizumab (Avastin)--and today is able to get on living her life.

This video is presented as part of the Cancer Research Institute 5th Annual Cancer Immunotherapy Month awareness campaign this June 2017. Learn more about cancer immunotherapy and its potential to save more lives at http://www.cancerresearch.org/june #CIM17